Extracorporeal membrane oxygenation in patients with COVID-19: 1-year experience.

ABSTRACT:

Background

Extracorporeal membrane oxygenation (ECMO) in patients with coronavirus disease 2019 (COVID-19) showed reasonable outcomes. However, recent studies indicated a negative trend and analysis is needed.

Methods

Baseline characteristics, laboratory parameters, and outcomes of ECMO-supported patients with COVID-19 were analyzed in a retrospective single-center study. We included hospital admissions until February 28, 2021; patients were followed until discharge/death. Eventually, we compared data between patients hospitalized before and after September 1, 2020.

Results

Median age of patients treated with ECMO (n=39) was 56 years; most patients were males (n=28, 72%). Median mechanical ventilation time (prior to ECMO) was 6 days, while the median ECMO duration was

SUBMITTER: Durak K 

PROVIDER: S-EPMC8575858 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature